AT1019

AT-1019

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AT1019, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study [Phase 1]